Related Experiment Video
Updated: Mar 23, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
The impact of genomics on health outcomes, quality, and safety
Kathleen A McCormick1, Kathleen A Calzone
1Kathleen A. McCormick is the principal/CEO of SciMind, LLC, in North Potomac, Md. Kathleen A. Calzone is a senior nurse specialist, research, Genetics Branch, at the National Institutes of Health's National Cancer Institute Center for Cancer Research in Bethesda, Md.
No abstract available in PubMed .
Related Concept Videos
Genomics
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenomics: Identification of New Drug Targets
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

